₨ 108.00
MBBS
BENSAR 5mg Tablet 10s
- Does this requires a prescription ? Yes
- Generic Name: Olmesartan Medoxomil:5mg
- Manufactured by : PharmEvo Private Limited
- Drug Strength : 5mg
- Drug Form : Tablet
- Pack Size : 10s
- Product SKU : dis_23456
Olmesartan Medoxomil:5mg | Angiotensin II receptor anatgonists
Alternate brands of BENSAR 5mg Tablet 10s
Brand Name | Price | Savings |
---|---|---|
OSCORD 5mg Tablet 10s | ₨ 108.00 | You can save 0 |
OSCORD 5mg Tablet 14s | ₨ 151.00 | You will pay -43 more |
NEGATIN 5mg Tablet 10 | ₨ 108.00 | You can save 0 |
NEGATIN 5mg Tablet 14 | ₨ 151.00 | You will pay -43 more |
BENSAR 5mg Tablet 14s | ₨ 151.00 | You will pay -43 more |
Manufactured / Marketed By : Pharmevo Product Form : TabletPack Size : 10sIngredients : Olmesartan Medoxomil:5mgGeneric Category : Angiotensin II receptor anatgonists
How it works
BENSAR 5mg Tablet 10s works by relaxing blood vessels so that blood can flow more easily.
Concerns
Frequently asked questions
-
Onset of action
-
Duration of Effect
-
Safe with Alchohol?
-
Is it habit forming?
-
Usage in pregnancy?
-
Usage while breast-feeding?
Dosage
-
Missed Dose
-
Overdose
References
- webmd.com - Olmesartan MEDOXOMIL [Internet]. Available from: https://www.webmd.com/drugs/2/drug-63172/olmesartan-oral/details [cited 20/7/2020].
One of the following licensed pharmacy from the nearest location will deliver BENSAR 5mg Tablet 10s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
-
-14% Out of stock
Download App
Download Android App
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.